Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Athira Pharma Inc ATHA

Healthcare
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline consists of both blood brain barrier permeable and peripherally restricted drug candidates for the central nervous system (CNS), peripheral nervous system, and other indications. Its lead candidate... see more

Recent & Breaking News (NDAQ:ATHA)

Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. - ATHA

Newsfile August 14, 2021

ROSEN, A TOP RANKED LAW FIRM, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHA

PR Newswire August 13, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, ATHA and QFIN

Accesswire August 13, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Athira Pharma (ATHA) Investors of AUGUST 24th INVESTOR DEADLINE in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys Now

Newsfile August 13, 2021

7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile August 13, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATHA, DIDI and PLL

Accesswire August 13, 2021

Athira Deadline Alert

Newsfile August 12, 2021

ATHIRA PHARMA INVESTOR NOTICE BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Shareholders with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA

Newsfile August 12, 2021

Lawsuits Filed Against ATHA, YMM and PLL - Jakubowitz Law Pursues Shareholders Claims

Accesswire August 12, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATHA, PLL and OTLY

Accesswire August 12, 2021

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile August 12, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATHA, RKT and QFIN

Accesswire August 12, 2021

ROSEN, LEADING INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - ATHA

Newsfile August 11, 2021

LAWSUITS FILED AGAINST ATHA, RKT and COIN - Jakubowitz Law Pursues Shareholders Claims

Accesswire August 11, 2021

Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Athira Pharma, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit

PR Newswire August 11, 2021

CLASS ACTION UPDATE for ATHA, RKT and CXO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire August 11, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATHA, RKT and PLL

Accesswire August 11, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athira Pharma (ATHA) Investors to AUGUST 24th APPLICATION DEADLINE in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys Now

Newsfile August 11, 2021

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile August 11, 2021

SHAREHOLDER ALERT: ATHA RKT ATVI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire August 11, 2021